Laboratory Standards and Procedures Subcommittee Meeting September 16, 2010

First Page		Document Content
Date: 2014-12-04 01:13:45 Health SMN1 Medical classification Multiplex LOINC Laboratory techniques Science Health informatics		Laboratory Standards and Procedures Subcommittee Meeting September 16, 2010 Add to Reading List Source URL: www.hrsa.gov Download Document from Source Website File Size: 24,79 KB Share Document on Facebook

	npg Call in the backup The most common genetic killer of infants, a disease known as spinal muscular atrophy, is caused by mutations in a single gene. The human genome contains its own backup system—near-identical cop DocID: 177oq - View Document
	ISIS INITIATES PHASE 1 CLINICAL STUDY OF ISIS-SMNRX IN PATIENTS WITH SPINAL MUSCULAR ATROPHY U.S. FDA has granted both Fast Track Status and Orphan Drug Designation for ISIS-SMNRx CARLSBAD, Calif., December 19, 2011 – DocID: 15Kdp - View Document
	ISSNBiopolymers and CellVol. 26. N 1 Implementation of the quantitative Real-Time PCR for the molecular-genetic diagnostics of spinal muscular atrophy O. O. Soloviov, G. B. Livshits, S. S. Podlesnaya DocID: 13lsk - View Document
	BioMed Research International Special Issue on Motor Neuron Disorders: Molecular Mechanisms of Pathogenesis and Therapeutic Developments CALL FOR PAPERS DocID: 12fvF - View Document
	Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 This study is a phase I, single-site, dose escalation study to evaluate the safety and efficacy of gene transfer for Spinal Muscular Atrophy Type 1 (SMA1). DocID: 11rVr - View Document